Literature DB >> 10441060

Quantitative electroencephalographic changes due to middle cerebral artery occlusion by endothelin 1 in conscious rats.

S Moyanova1, L Kortenska, R Kirov, I Iliev.   

Abstract

The powerful vasoconstrictor peptide endothelin-1 (ET1) has been shown to reduce local cerebral blood flow in brain areas supplied by the middle cerebral artery (MCA) to a pathologically low level upon intracerebral injection adjacent to the MCA. This reduction manifests itself as an ischemic infarct, that is fully developed within 3 days after ET1 injection. The aim of the present study is to examine the effect of ET1 on electroencephalographic (EEG) activity. ET1 was microinjected unilaterally at a dose of 60 pmol in 3 microl of saline to the MCA in conscious rats. EEG signals were recorded from the frontoparietal cortical area, supplied by MCA, from the first up to the fourteenth day after ET1 injection. EEG activity was analyzed by the fast Fourier transformation. A significant shift to a lower EEG frequency, i.e., augmentation of slow waves and a reduction of alpha-like and faster EEG waves was found post-ET1. This effect was maximal after 3-7 days when the most severe destruction of neurons in this cortical area occurs, as has been previously demonstrated. The results suggest that the quantitative EEG analysis may provide useful additional information about the functional disturbances associated with focal cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10441060     DOI: 10.1076/apab.106.5.384.4362

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  7 in total

Review 1.  Epileptogenesis after experimental focal cerebral ischemia.

Authors:  Heli Karhunen; Jukka Jolkkonen; Juhani Sivenius; Asla Pitkänen
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

2.  Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats.

Authors:  Huong L Moldthan; Aaron C Hirko; Jeffrey S Thinschmidt; Maria B Grant; Zhimin Li; Joanna Peris; Yuanqing Lu; Ahmed S Elshikha; Michael A King; Jeffrey A Hughes; Sihong Song
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-02-28       Impact factor: 2.136

3.  The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo.

Authors:  Alexandra B Lämmer; Alexander Beck; Benjamin Grummich; Annette Förschler; Thomas Krügel; Thomas Kahn; Dietmar Schneider; Peter Illes; Heike Franke; Ute Krügel
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

4.  The protective effects of plasma gelsolin on stroke outcome in rats.

Authors:  Huong T Le; Aaron C Hirko; Jeffrey S Thinschmidt; Maria Grant; Zhimin Li; Joanna Peris; Michael A King; Jeffrey A Hughes; Sihong Song
Journal:  Exp Transl Stroke Med       Date:  2011-11-02

Review 5.  Perturbation of Brain Oscillations after Ischemic Stroke: A Potential Biomarker for Post-Stroke Function and Therapy.

Authors:  Gratianne Rabiller; Ji-Wei He; Yasuo Nishijima; Aaron Wong; Jialing Liu
Journal:  Int J Mol Sci       Date:  2015-10-26       Impact factor: 5.923

Review 6.  Microcirculatory Changes in Experimental Models of Stroke and CNS-Injury Induced Immunodepression.

Authors:  Sarah Lunardi Baccetto; Christian Lehmann
Journal:  Int J Mol Sci       Date:  2019-10-19       Impact factor: 5.923

7.  Age-dependence of sensorimotor and cerebral electroencephalographic asymmetry in rats subjected to unilateral cerebrovascular stroke.

Authors:  Slavianka G Moyanova; Rumiana G Mitreva; Lidia V Kortenska; Ferdinando Nicoletti; Richard T Ngomba
Journal:  Exp Transl Stroke Med       Date:  2013-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.